154 related articles for article (PubMed ID: 25870963)
1. Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.
Lehmann S; Delaby C; Paquet C; Gabelle A
Clin Chem Lab Med; 2015 Jul; 53(8):e175-7. PubMed ID: 25870963
[No Abstract] [Full Text] [Related]
2. Biomarkers reflecting different facets of Alzheimer's disease.
Zetterberg H
Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
[No Abstract] [Full Text] [Related]
3. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
Prvulovic D; Hampel H
Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
[TBL] [Abstract][Full Text] [Related]
4. [Biomarker and imaging of Alzheimer's disease].
Kawarabayashi T; Shoji M
No To Shinkei; 2005 Oct; 57(10):839-52. PubMed ID: 16277229
[No Abstract] [Full Text] [Related]
5. [Markers of prodromal Alzheimer's disease].
de Souza LC; Sarazin M; Uspenskaya O; Habert MO; Lamari F; Lehéricy S; Dubois B
Rev Neurol (Paris); 2012 Nov; 168(11):815-24. PubMed ID: 22944619
[TBL] [Abstract][Full Text] [Related]
6. Biological markers in Alzheimer's disease.
Grundke-Iqbal I; Rolkova G; Konstekova E; Iqbal K
Bratisl Lek Listy; 2006; 107(9-10):359-65. PubMed ID: 17262988
[TBL] [Abstract][Full Text] [Related]
7. The utility of the new research diagnostic criteria for Alzheimer's disease.
Dubois B; Gauthier S; Cummings J
Int Psychogeriatr; 2013 Feb; 25(2):175-7. PubMed ID: 23148941
[No Abstract] [Full Text] [Related]
8. Biochemical Markers in Alzheimer's Disease.
Rabbito A; Dulewicz M; Kulczyńska-Przybik A; Mroczko B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183332
[TBL] [Abstract][Full Text] [Related]
9. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.
Dubois B; Villain N; Frisoni GB; Rabinovici GD; Sabbagh M; Cappa S; Bejanin A; Bombois S; Epelbaum S; Teichmann M; Habert MO; Nordberg A; Blennow K; Galasko D; Stern Y; Rowe CC; Salloway S; Schneider LS; Cummings JL; Feldman HH
Lancet Neurol; 2021 Jun; 20(6):484-496. PubMed ID: 33933186
[TBL] [Abstract][Full Text] [Related]
10. An ideal biological marker of Alzheimer's disease: dream or reality?
Rípová D; Strunecká A
Physiol Res; 2001; 50(2):119-29. PubMed ID: 11522040
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
12. Analytical aspects of molecular Alzheimer's disease biomarkers.
Andreasson U; Vanmechelen E; Shaw LM; Zetterberg H; Vanderstichele H
Biomark Med; 2012 Aug; 6(4):377-89. PubMed ID: 22917140
[TBL] [Abstract][Full Text] [Related]
13. The role of biomarkers in clinical trials for Alzheimer disease.
Thal LJ; Kantarci K; Reiman EM; Klunk WE; Weiner MW; Zetterberg H; Galasko D; Praticò D; Griffin S; Schenk D; Siemers E
Alzheimer Dis Assoc Disord; 2006; 20(1):6-15. PubMed ID: 16493230
[TBL] [Abstract][Full Text] [Related]
14. Are CSF biomarkers ready for prime time as diagnostics for Alzheimer disease? Interview by Rebecca Voelker.
Holtzman DM
JAMA; 2010 Nov; 304(17):1887. PubMed ID: 21045090
[No Abstract] [Full Text] [Related]
15. [Amyloid and tau imaging, its present and future].
Okamura N; Harada R; Kudo Y; Yanai K
Nihon Yakurigaku Zasshi; 2015 Sep; 146(3):144-9. PubMed ID: 26354014
[No Abstract] [Full Text] [Related]
16. Bacterial contamination and the transport vial material affect cerebrospinal fluid concentrations of β-Amyloid and Tau protein as determined by enzyme immunoassay.
Fronek K; Lange P; Spreer A; Eiffert H; Nau R
Dement Geriatr Cogn Disord; 2011; 32(2):126-34. PubMed ID: 21952521
[TBL] [Abstract][Full Text] [Related]
17. [Biomarkers of Alzheimer disease].
Rachel W; Grela A; Zyss T; Zieba A; Piekoszewski W
Przegl Lek; 2014; 71(2):98-101. PubMed ID: 25016785
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of Alzheimer's disease: the present and the future.
Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A
Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.
Morris JC; Selkoe DJ
Neurobiol Aging; 2011 Dec; 32 Suppl 1():S1-3. PubMed ID: 22078168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
